Transfusions are very safe in 2016, but is there a way to get rid of the remaining potential “bugs in the bag?” Well, yes, but pathogen inactivation is not yet fully implemented in the United States. Dr. Jeff McCullough explains.

Dr. Jeff McCullough

Dr. Jeff McCullough

Most everyone would agree that blood transfusion in 2016 is really, really safe from potential infectious disease transmission. At the same time, there are a few situations that worry blood bankers, including the residual risk of bacterial contamination of platelets (despite increased efforts in recent years to detect such contamination) and emerging infections like Zika, Dengue, and Chikungunya viruses. One potential solution to these issues is called “pathogen inactivation” (also called pathogen reduction by many). This is simply a method to treat blood products after they are collected in order to remove residual organisms that either were not detected by current tests or for which we do not yet have a test (and further, may not even know about the organism!). Dr. McCullough shares the basics of the two main types of pathogen inactivation platforms under discussion for current and future use in the United States (both of which are already used in many other countries).

Never miss an episode. Subscribe on Apple Podcasts to get new episodes as they become available.

Listen on Google Play Music

DISCLAIMER: The opinions expressed on this episode are those of my guest and I alone, and do not reflect those of the organizations with which either of us is affiliated. Neither Dr. McCullough nor I have any relevant financial disclosures (discussed during the first five minutes of the episode).

Pin It on Pinterest